Last updated: July 07, 2026

Application No. 18/800,215

Untitled Application

Unknown

Filed

Priority

Apr 12, 2019 — provisional 62/833,527 +4 more

Examiner

SHAMEEM, GOLAM M

Art Unit

Tech Center

Blueprint Medicines Corporation

Assignee

Blueprint Medicines Corporation

OA Round

1 (Non-Final)

Interview Optional

— +15.8% interview lift. Examiner has a relatively high allowance rate (87%); +15.8% interview lift. A written response may suffice.

Based on 887 resolved cases, 2023–2026

Examiner Intelligence

SHAMEEM, GOLAM M View full profile →

Grants 87% — above average

Career Allowance Rate

769 granted / 887 resolved

+26.7% vs TC avg

Strong +16% interview lift

Without

With

+15.8%

Interview Lift

resolved cases with interview

Fast prosecutor

1y 10m

Avg Prosecution

38 currently pending

Career history

902

Total Applications

across all art units

Statute-Specific Performance

§101

0.5%

-39.5% vs TC avg

§103

3.2%

-36.8% vs TC avg

§102

6.5%

-33.5% vs TC avg

§112

13.4%

-26.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 887 resolved cases

Precedent Cases

Applications granted by this same examiner with similar technology

17/779,699

Patent 12660818

STRIGOLACTONE ANALOGS AND METHODS OF USING

4y 1m to grant Granted Jun 23, 2026

17/846,830

Patent 12662453

HETEROCYCLIC COMPOUND AND USE THEREOF

4y 0m to grant Granted Jun 23, 2026

18/261,949

Patent 12661405

PROTECTED HDAC (HISTONE DEACETYLASE) INHIBITORS

2y 11m to grant Granted Jun 23, 2026

18/759,546

Patent 12655118

cGAS ANTAGONIST COMPOUNDS

1y 11m to grant Granted Jun 16, 2026

17/914,932

Patent 12649719

MODULATORS OF HEMOGLOBIN

3y 8m to grant Granted Jun 09, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

87%

Grant Probability

99%

With Interview (+15.8%)

1y 10m

Median Time to Grant

Low

PTA Risk

Based on 887 resolved cases by this examiner. Grant probability derived from career allowance rate.